BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15941852)

  • 21. Identification of regions within the F domain of the human estrogen receptor alpha that are important for modulating transactivation and protein-protein interactions.
    Koide A; Zhao C; Naganuma M; Abrams J; Deighton-Collins S; Skafar DF; Koide S
    Mol Endocrinol; 2007 Apr; 21(4):829-42. PubMed ID: 17185393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERR-10: a new repressor in transcriptional signaling activation of estrogen receptor-alpha.
    Meng Q; Zhao Z; Yan M; Zhou L; Li J; Kitt C; Bin G; Fan S
    FEBS Lett; 2004 Oct; 576(1-2):190-200. PubMed ID: 15474036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells.
    Bryant W; Snowhite AE; Rice LW; Shupnik MA
    Endocrinology; 2005 Feb; 146(2):751-9. PubMed ID: 15528307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1).
    Zhou D; Quach KM; Yang C; Lee SY; Pohajdak B; Chen S
    Mol Endocrinol; 2000 Jul; 14(7):986-98. PubMed ID: 10894149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
    Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
    Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
    Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter.
    Ellison-Zelski SJ; Solodin NM; Alarid ET
    Mol Cell Biol; 2009 Sep; 29(18):4949-58. PubMed ID: 19620290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.
    Teyssier C; Belguise K; Galtier F; Cavailles V; Chalbos D
    Mol Endocrinol; 2003 Feb; 17(2):287-99. PubMed ID: 12554755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells.
    Kanaujiya JK; Lochab S; Kapoor I; Pal P; Datta D; Bhatt ML; Sanyal S; Behre G; Trivedi AK
    Proteomics; 2013 Jul; 13(14):2100-12. PubMed ID: 23576398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between transcription factor, basal transcription factor 3, and the NH2-terminal domain of human estrogen receptor alpha.
    Green CD; Thompson PD; Johnston PG; El-Tanani MK
    Mol Cancer Res; 2007 Nov; 5(11):1191-200. PubMed ID: 18025262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen.
    Kressler D; Hock MB; Kralli A
    J Biol Chem; 2007 Sep; 282(37):26897-26907. PubMed ID: 17631495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation.
    Arao Y; Korach KS
    J Biol Chem; 2018 Jun; 293(22):8495-8507. PubMed ID: 29632071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domain.
    Voss TC; Demarco IA; Booker CF; Day RN
    Mol Cell Endocrinol; 2005 Feb; 231(1-2):33-47. PubMed ID: 15713534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.
    Loven MA; Muster N; Yates JR; Nardulli AM
    Mol Endocrinol; 2003 Jan; 17(1):67-78. PubMed ID: 12511607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.